Abstracts tagged "CLASI"

Abstract Number: 861 • ACR/ARP Annual Meeting 2019

Cutaneous Lupus Erythematosus Disease Area & Severity Index (CLASI) Demonstrates Thresholds for Detection of Treatment Response in a Phase-2, Placebo-Controlled Trial of Ustekinumab in SLE

Victoria Werth¹, Bevra Hahn ², George Tsokos ³, Shawn Rose ⁴, Kaiyin Fei ⁴, Yun Gregan ⁴, Robert Gordon ⁴, Kim Hung Lo ⁴ and Ronald van Vollenhoven ⁵, ¹Hospital of the Univ of PA and Veteran’s Administration Med Center, Philadelphia, PA, ²University of California, Los Angeles, CA, ³Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, ⁴Janssen Research & Development, LLC, Spring House, PA, ⁵Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands